XML 50 R37.htm IDEA: XBRL DOCUMENT
v3.24.1

Investment in Associates (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Investment in Associates and Investments in Investees [Abstract] |
Schedule of Fair Value of the Investment | The table below summarizes the fair value of the investment in MitoCareX:
Balance at January 1, 2022 |  | $ | - |
Investment date March 31, 2022 |  |  | 700 |
Equity losses from investment in MitoCareX |  |  | (109 | )
Balance at December 31, 2022 |  | $ | 591 |
Investment following achievement of first milestone |  |  | 400 |
Equity losses from investment in MitoCareX |  |  | (210 | )
Balance at December 31, 2023 |  |  | 781 |

X
- Definition The disclosure of the fair value measurement of liabilities. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2023-01-01 -Paragraph 93 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2023-en-r&anchor=para_93&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementOfLiabilitiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_InvestmentinAssociatesTablesLineItems
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration